Mas Receptor Agonism Attenuates Seizures in a Pentylenetetrazole Kindling Model of Experimental Epilepsy in Mice
Long-term administration of the Mas receptor agonist AVE 0991 attenuates PTZ-induced seizure severity, anxiety, and cognitive impairment in mice by modulating MasR, NR2B, and BDNF mRNA expression, suggesting its potential as a therapeutic strategy for epilepsy.